Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boostrix and MenACWY concomitant administration study in healthy adolescents and young adults
2005-005519-12Phase 3Completed
- Sponsor
- Chiron Corporation
- Start
- Jun 2006
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of acellular pertussis vaccine and meningococcal conjugate vaccine in meningococcal disease, diphtheria, Tetanus and 1 more (3 arms), sponsored by Chiron Corporation. Primary endpoints: Diphtheria seroprotection rate at 1 month, Tetanus seroprotection rate at 1 month and 1 more. Started Jun 2006; status: completed.
02
Drugs
acellular pertussis vaccinemeningococcal conjugate vaccine
03
Conditions
meningococcal diseasediphtheriaTetanuspertussis
Beyond the preview
Go deeper on 2005-005519-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005519-12.